North Ridge Wealth Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$32.1K Hold
530
0.02% 98
2025
Q4
$28.6K Hold
530
0.02% 98
2025
Q3
$23.9K Hold
530
0.01% 108
2025
Q2
$24.5K Hold
530
0.02% 98
2025
Q1
$32.3K Hold
530
0.02% 83
2024
Q4
$30K Buy
+530
New +$29.6K 0.02% 88

Other funds holding BMY

North Ridge Wealth Advisors's BMY Position: Q1 2026 in Review

North Ridge Wealth Advisors held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 530 shares worth $32.1K. The position accounts for 0.02% of the portfolio, ranked #98.

North Ridge Wealth Advisors first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $32.3K in Q1 2025. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • North Ridge Wealth Advisors held 530 shares of Bristol-Myers Squibb worth $32.1K as of Q1 2026.
  • North Ridge Wealth Advisors left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.02% of North Ridge Wealth Advisors's portfolio in Q1 2026, its #98 holding.
  • North Ridge Wealth Advisors first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • North Ridge Wealth Advisors's Bristol-Myers Squibb position peaked at $32.3K in Q1 2025.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on North Ridge Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.